Zacks upgraded shares of Alcobra Ltd. (NASDAQ:ADHD) from a neutral rating to an outperform rating in a report released on Friday. On Tuesday shares of Alcobra Ltd. (NASDAQ:ADHD) closed at $7.48.
Tesla Motors Inc (NASDAQ:TSLA) has successfully launched electric vehicles, but so far its model lineup consists of luxury cars and mass market success remains elusive. Toyota’s Prius is the closest thing to a hit in the industry, but it’s a hybrid — plug-in electric cars have yet to hit the mainstream. On Tuesday shares of Tesla Motors Inc (NASDAQ:TSLA) closed at $204.35. Company’s sales growth for last 5 years was 167.50% and EPS growth for next 5 years is recorded as 73.77%.
On 11 February 2015, Pandora Media Inc. (NYSE:P) subscribers urged the Ninth Circuit to revive their proposed class action claiming the music service violated Michigan’s Video Rental Privacy Act by disclosing their listening habits, arguing the lower court wrongly tossed the suit after finding Pandora isn’t a “lender” under that law. On Tuesday shares of Pandora Media Inc (NYSE:P) closed at $15.01. Company’s sales growth for last 5 years was 75.60% and EPS growth for next 5 years is recorded as 43.03%.
On 5 February 2015, Oxford Immunotec Global PLC (NASDAQ:OXFD) announced that the first patients have been enrolled in a pivotal clinical trial of its T-SPOTCMV and T-SPOT.PRT products. Oxford Immunotec Global PLC (NASDAQ:OXFD) has 0.20% insider ownership while its institutional ownership stands at 58.30%. In last trading activity company’s stock closed at $12.92.
Amgen Inc (NASDAQ:AMGN) and a partnership of Sanofi and Regeneron Pharmaceuticals Inc are awaiting U.S. approval of their rival PCSK9 inhibitors. They are expected to be approved for patients who are genetically prone to high levels of cholesterol – a population that CVS pegs at 620,000 Americans. On last trading day Amgen Inc. (NASDAQ:AMGN) increased 0.50% to close at $154.24. Its volatility for the week is 2.08% while volatility for the month is 2.61%. AMGN’s sales growth for past 5 years was 6.50% and its EPS growth for past 5 years was 8.20%. Amgen Inc. (NASDAQ:AMGN) monthly performance is 2.06%.